Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF: PFRM3)

PFRM3 Statistics

Total Valuation

Profarma Distribuidora de Produtos Farmacêuticos has a market cap or net worth of BRL 838.66 million. The enterprise value is 2.06 billion.

Market Cap	838.66M
Enterprise Value	2.06B

Important Dates

The last earnings date was Wednesday, October 30, 2024.

Earnings Date	Oct 30, 2024
Ex-Dividend Date	Dec 2, 2024

Share Statistics

Profarma Distribuidora de Produtos Farmacêuticos has 122.61 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	122.61M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.45%
Owned by Institutions (%)	19.41%
Float	40.68M

Valuation Ratios

The trailing PE ratio is 7.81.

PE Ratio	7.81
Forward PE	n/a
PS Ratio	0.09
PB Ratio	0.63
P/TBV Ratio	n/a
P/FCF Ratio	2.23
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.70, with an EV/FCF ratio of 5.48.

EV / Earnings	19.19
EV / Sales	0.22
EV / EBITDA	4.70
EV / EBIT	6.80
EV / FCF	5.48

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.72.

Current Ratio	1.41
Quick Ratio	0.75
Debt / Equity	0.72
Debt / EBITDA	2.67
Debt / FCF	3.12
Interest Coverage	1.95

Financial Efficiency

Return on equity (ROE) is 7.41% and return on invested capital (ROIC) is 6.99%.

Return on Equity (ROE)	7.41%
Return on Assets (ROA)	3.87%
Return on Capital (ROIC)	6.99%
Revenue Per Employee	1.32M
Profits Per Employee	15,182
Employee Count	7,077
Asset Turnover	1.91
Inventory Turnover	5.19

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +36.80% in the last 52 weeks. The beta is 1.25, so Profarma Distribuidora de Produtos Farmacêuticos's price volatility has been higher than the market average.

Beta (5Y)	1.25
52-Week Price Change	+36.80%
50-Day Moving Average	6.26
200-Day Moving Average	5.78
Relative Strength Index (RSI)	52.63
Average Volume (20 Days)	404,405

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Profarma Distribuidora de Produtos Farmacêuticos had revenue of BRL 9.34 billion and earned 107.45 million in profits. Earnings per share was 0.88.

Revenue	9.34B
Gross Profit	1.44B
Operating Income	303.27M
Pretax Income	132.37M
Net Income	107.45M
EBITDA	331.87M
EBIT	303.27M
Earnings Per Share (EPS)	0.88

Balance Sheet

The company has 231.28 million in cash and 1.17 billion in debt, giving a net cash position of -941.06 million or -7.68 per share.

Cash & Cash Equivalents	231.28M
Total Debt	1.17B
Net Cash	-941.06M
Net Cash Per Share	-7.68
Equity (Book Value)	1.62B
Book Value Per Share	10.92
Working Capital	1.05B

Cash Flow

In the last 12 months, operating cash flow was 468.75 million and capital expenditures -92.92 million, giving a free cash flow of 375.83 million.

Operating Cash Flow	468.75M
Capital Expenditures	-92.92M
Free Cash Flow	375.83M
FCF Per Share	3.07

Margins

Gross margin is 15.40%, with operating and profit margins of 3.25% and 1.15%.

Gross Margin	15.40%
Operating Margin	3.25%
Pretax Margin	1.42%
Profit Margin	1.15%
EBITDA Margin	3.55%
EBIT Margin	3.25%
FCF Margin	4.02%

Dividends & Yields

This stock pays an annual dividend of 0.58, which amounts to a dividend yield of 8.52%.

Dividend Per Share	0.58
Dividend Yield	8.52%
Dividend Growth (YoY)	-62.47%
Years of Dividend Growth	n/a
Payout Ratio	38.73%
Buyback Yield	n/a
Shareholder Yield	8.52%
Earnings Yield	12.81%
FCF Yield	44.81%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Profarma Distribuidora de Produtos Farmacêuticos has an Altman Z-Score of 2.45. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.45
Piotroski F-Score	n/a